Adma Biologics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+8.64%
vs ±11.7% implied · ×0.74
shaded = implied · ▲▼ = realized
No thesis.
Fund move
Fund move
Adma Biologics, Inc.
11.41
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $321.0M | 18.50% | +4.14% | |
| 2 | State StreetState Streetindex-like | $143.3M | 8.26% | +21.53% | |
| 3 | Vanguard Capital ManagementVanguardindex-like | $84.6M | 4.87% | −1.97% | |
| 4 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $84.4M | 4.87% | +13.75% | |
| 5 | Rubric Capital ManagementRubric | $78.2M | 4.50% | +416.16% | |
| 6 | Capital Research Global InvestorsCapital Research Global Investors | $73.3M | 4.22% | −21.76% | |
| 7 | First Trust AdvisorsFirst Trust | $65.3M | 3.76% | +2064.90% | |
| 8 | Geode Capital ManagementGeodeindex-like | $50.7M | 2.92% | +4.05% | |
| 9 | Caligan PartnersCaligan Partners | $50.4M | 2.91% | +19.15% | |
| 10 | D. E. ShawD. E. Shaw | $44.1M | 2.54% | +840.50% | |
| 11 | Dimensional Fund AdvisorsDimensional | $30.2M | 1.74% | −27.95% | |
| 12 | Goldman Sachs GroupGoldman Sachs | $29.4M | 1.69% | +25.33% | |
| 13 | B GroupB Group | $27.3M | 1.57% | +1.71% | |
| 14 | NuveenNuveenindex-like | $27.3M | 1.57% | −46.54% | |
| 15 | Duquesne Family OfficeDuquesne Family Office | $23.3M | 1.34% | +80.13% | |
| 16 | Northern TrustNorthern Trustindex-like | $20.2M | 1.17% | +6.09% | |
| 17 | Nantahala Capital ManagementNantahala | $19.8M | 1.14% | new | |
| 18 | Morgan StanleyMorgan Stanley | $19.0M | 1.09% | −6.94% | |
| 19 | Ranger Investment ManagementRanger | $17.7M | 1.02% | −7.37% | |
| 20 | Charles Schwab Investment ManagementCharles Schwabindex-like | $17.5M | 1.01% | −0.15% | |
| 21 | Caption ManagementCaption | $16.9M | 0.97% | −39.41% | |
| 22 | Two Sigma InvestmentsTwo Sigma | $16.9M | 0.97% | −3.45% | |
| 23 | Kennedy Capital ManagementKennedy | $14.7M | 0.85% | +326.68% | |
| 24 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $13.8M | 0.80% | +1.04% | |
| 25 | FundsmithFundsmith | $13.8M | 0.80% | 0.00% |
323 managers report $1.7B of Adma Biologics on form 13F for the quarter ended Jun 30 '26. 32 of them hold 80% of it; BlackRock is largest at 18.50%.
Expected move
Inputs8Q avg ±8.0%·×0.20·cheap
straddle ±11.0%
spot 11.41exp Nov 20ATM strike 11ATM straddle 1.47IV 67%